Brief report · 1 Dec 2025
EditorialPublished 2017
The Place of Biological Markers to Predict the Response after Neoadjuvant Treatment in Esophageal Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Esophageal cancer remains one of the most severe malignancies in terms of overall survival despite the introduction of novel radiation regimens and chemotherapy agents. Many of the patients are diagnosed in advanced cases in which a multimodal treatment protocol is applied, finding the biomarkers that are involved in the resistance to neoadjuvant treatment could select the subgroup of patients that could be submitted either to surgical treatment or to an experimental drug trial. Hereby, we reviewed the potential biomarkers (immunohistochemical, blood-based, miRNA markers and gene expression profiling) that promised novel therapeutic pathways protocols.
Subjects
SurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Surgery.
Brief report · 1 Dec 2025
Surgical Checklists: Improving Safety and Efficiency
Commentary · 1 Dec 2025
Thermal Injury In Vascular Surgery: Minimizing Risks
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Surgery
- SubjectSurgery
- BylineArticles whose byline prints “Mircea Costache”
- BylineArticles whose byline prints “Bogdan Filip”
- BylineArticles whose byline prints “Dragos Viorel Scripcariu”
- BylineArticles whose byline prints “Nicolae Danila”
- BylineArticles whose byline prints “Viorel Scripcariu”

